Warfarin associated intracerebral hemorrhage in Hong Kong Chinese

Neurological Research

Volumn 36, Issue 2, 2014, Pages 143-149

  Teo, K C ^a   Mahboobani, N R ^a   Lee, R ^a   Siu, C W ^a   Cheung, R T F ^a   Ho, S L ^a   Lau, K K ^a   Chan, K H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ICH volume; Intracerebral hemorrhage; Intraventricular extension; Mortality; Neurological deterioration; Warfarin; Warfarin associated ICH

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN HEMORRHAGE VOLUME; BRAIN ISCHEMIA; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK;

ICH VOLUME,; INTRACEREBRAL HEMORRHAGE,; INTRAVENTRICULAR EXTENSION,; MORTALITY,; NEUROLOGICAL DETERIORATION; WARFARIN,; WARFARIN-ASSOCIATED ICH,;

AGED; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BRAIN; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; WARFARIN;

EID: 84893005960     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000275     Document Type: Article

References (47)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133(6 Suppl):160S-98S.
2. Hart RG, Aguilar MI. Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage. J Throm Thrombolysis. 2008;25:26-32.
3. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005;36:1588-93.
4. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke. 1995; 26:1471-77.
5. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37:256-62.
6. Liotta EM, Prabhakaran S. Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States. J Stroke Cerebrovasc Dis. 2013;22:1151-5.
7. Franke CL, de Jonge J, van Swieten JC, Op de Coul AA, van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990;21:726-30.
8. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patient with intracerebral hemorrhage. Stroke. 1997;28:1-5.
9. Fogelholm R, Murros K, Rissanen A, Avikainen S. Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry. 2005;76:1534-8.
10. Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66:1182-6.
11. Huttner HB, Schellinger PD, Hartmann M, Köhrmann M, Juettler E, Wikner J, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: complication of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465-70.
12. Lee SB, Manno EM, Layton KF, Wijdicks EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology. 2006;67:1272-74.
13. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-4.
14. Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B, et al. Warfain use leads to larger intracerebral hematomas. Neurology. 2008;71:1084-89.
15. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J. Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke. 2000;31:2558-62.
16. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol. 2008;65:1320-25.
17. Biffi A, Battey TW, Ayres AM, Cortellini L, Schwab K, Gilson AJ, et al. Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology. 2011;77:1840-6.
18. Garg RK, Liebling SM, Mass MB, Nemeth AJ, Russell EJ, Naidech AM. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke. 2012;43:67-71.
19. Hylek EM, Singer DE. Risk factors for intracerebral hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
20. Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1992; 55:1121-24.
21. Flaherty ML, Haverbusch M, Sekar P, Kissela BM, Kleindorfer D, Moomaw CJ, et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit care. 2006;5:197-201.
22. Secil Y, Ciftci Y, Tokucoglu F, Beckmann Y. Intracranial hemorrhage related with warfarin use and comparison of warfarin and acetylsalicylic acid. J Stroke Cerebrovasc Dis. 2013. Apr 3. [Epub ahead of print]. doi: 10.1016/j. jstrokecerebrovasdis.2013. 03.008.
23. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P; CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke. 2008;39:2993-96.
24. Flibotte JJ, Hagan N, J O'Donnell, Greenberg SM, Rosand J. Warfarin, hematoma expansion and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-64.
25. Rowe AS, Turner RM. Coagulation factor VIIa (recombinant) for warfarin induced intracranial hemorrhage. Am J Health Syst Pharm. 2010;67:361-65.
26. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R, et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke. 2006;37:151-5.
27. Menzin J, Hoesche J, Friedman M, Nichols C, Bergman GE, Crowther M, et al. Failure to correct international normalized ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost. 2012;10:596-605.
28. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, García RC, et al. Treatment of warfarin-associated intracerebral hemorrhage literature review and expert opinion. Mayo Clin Proc. 2007;82:82-92.
29. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG Jr, Czervionke LF, et al. Recombinant Factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clinic Proc. 2004;79:1495-500.
30. Sorensen B, Johansen P, Nielsen GL, Sørensen JC, Ingerslev J. Reversal of international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis. 2003;14:469-77.
31. Brody DL, Aiyagari V, Shackleford AM, Diringer MN. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit care. 2005;2:236-7.
32. Selim MH, Molina CA. The role of hemostatic therapy in anticoagulation-associated intracerebral hemorrhage: intuition versus evidence. Stroke. 2012;43:2539-40.
33. Diringer MN, Zazulia AR. Hemostatic therapy should be used for acute treatment of anticoagulation-related intracerebral hemorrhage. Stroke. 2012;43:2535-6.
34. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurological deterioration in non comatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-84.
35. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al. Early neurological deterioration in intracerebral hemorrhage. Neurology. 2004;63:461-67.
36. Flemming KD, Wijdicks EF, St Louis EK, Li H. Predicting deterioration in patients with lobar haemorrhages. J Neurol Neurosurg Psychiatry. 1999;66:600-5.
37. Qureshi AI, Safdar K, Weil J, Barch C, Bliwise DL, Colohan AR, et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke. 1995;26:1764-67.
38. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomized pilot trial. Lancet Neurol. 2008;7:391-9.
39. Qureshi AI, Tariq N, Divani AA, et al. Antihypertensive treatment of acute cerebral hemorrhage trial. Crit Care Med. 2010;38:637-48.
40. Prabhakaran S, Gupta R, Ouyang B, John S, Temes RE, Mohammad Y, et al. Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study. Stroke. 2010;41:48-53.
41. Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke. 2000;31:123-7.
42. Hanger HC, Wilkinson TJ, Fayez N-Iskander, Sainsbury R. The risk of recurrent stroke after intracerebral hemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:836-40.
43. Zia E, Engström G, Svensson PJ, Norrving B, Pessah-Rasmussen H. Three-year survival and stroke recurrence rate in patients with primary intracerebral hemorrhage. Stroke. 2009;40:3567-73.
44. Bailey RD, Hart RG, Benavente O, Pearce LA. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology. 2001;56:773-7.
45. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long term prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002;59:205-9.
46. Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, et al. Use of aspirin in Chinese after recovery from primary intracranial hemorrhage. Thromb Haemost. 2012;107:241-7.
47. Ariesen MJ, Claus CP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systemic review. Stroke. 2003;34:2060-5.